Tirzepatide After Sleeve Gastrectomy for Obesity
Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss
- Age
- 18 – 65
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 42 (estimated)
- Sponsor
- Nicholas Skertich · Other
This trial is looking for adults with obesity who are undergoing sleeve gastrectomy surgery. Participants will take the medication tirzepatide to see if it helps them lose more weight and improve related health conditions after surgery.
You may be able to join if
- I am between 18 and 65 years old.
- I have a Body Mass Index (BMI) over 35 with health issues like Type 2 diabetes or high blood pressure.
- I have a BMI over 40.
- I am having primary sleeve gastrectomy surgery.
You may not be able to join if
- I have had metabolic or bariatric surgery before.
- I have used a GLP-1 agonist
- I have a history of pancreatitis.
- I have a personal or family history of medullary thyroid cancer.
- I have an eating disorder.
- I am pregnant or breastfeeding.
- I have had a heart attack or stroke.
- I have active cancer.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis study examines whether adding tirzepatide-a medication that helps with weight loss-after sleeve gastrectomy surgery can help people lose more weight after the surgery; better improve conditions like Type 2 diabetes, high blood pressure, high cholesterol, and sleep apnea after surgery and; whether this causes more complications or side effects compared to surgery alone.
Loading trial locations…